JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patientsJing Qian, Yongqian Shu, Jin Xu et al.|Oncotarget|2016Cited by 11
Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective studyWeiyou Zhu, Xiaofeng Chen, Oluf Dimitri Røe et al.|Journal of Chemotherapy|2015Cited by 9